199 related articles for article (PubMed ID: 36526813)
1. Risk of Gastrointestinal Bleeding with Concurrent Use of NSAID and SSRI: A Systematic Review and Network Meta-Analysis.
Haghbin H; Zakirkhodjaev N; Husain FF; Lee-Smith W; Aziz M
Dig Dis Sci; 2023 May; 68(5):1975-1982. PubMed ID: 36526813
[TBL] [Abstract][Full Text] [Related]
2. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
Anglin R; Yuan Y; Moayyedi P; Tse F; Armstrong D; Leontiadis GI
Am J Gastroenterol; 2014 Jun; 109(6):811-9. PubMed ID: 24777151
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis.
Alam SM; Qasswal M; Ahsan MJ; Walters RW; Chandra S
Sci Rep; 2022 Aug; 12(1):14452. PubMed ID: 36002638
[TBL] [Abstract][Full Text] [Related]
4. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
Andrade C; Sandarsh S; Chethan KB; Nagesh KS
J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
[TBL] [Abstract][Full Text] [Related]
5. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.
Dalton SO; Johansen C; Mellemkjaer L; Nørgård B; Sørensen HT; Olsen JH
Arch Intern Med; 2003 Jan; 163(1):59-64. PubMed ID: 12523917
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs.
Loke YK; Trivedi AN; Singh S
Aliment Pharmacol Ther; 2008 Jan; 27(1):31-40. PubMed ID: 17919277
[TBL] [Abstract][Full Text] [Related]
7. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
8. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.
Jiang HY; Chen HZ; Hu XJ; Yu ZH; Yang W; Deng M; Zhang YH; Ruan B
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):42-50.e3. PubMed ID: 24993365
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?
Yuan Y; Tsoi K; Hunt RH
Am J Med; 2006 Sep; 119(9):719-27. PubMed ID: 16945603
[TBL] [Abstract][Full Text] [Related]
10. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature.
Mort JR; Aparasu RR; Baer RK
Pharmacotherapy; 2006 Sep; 26(9):1307-13. PubMed ID: 16945053
[TBL] [Abstract][Full Text] [Related]
11. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.
Ahsberg K; Höglund P; Kim WH; von Holstein CS
Scand J Gastroenterol; 2010 Dec; 45(12):1404-15. PubMed ID: 20695720
[TBL] [Abstract][Full Text] [Related]
12. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding.
Dall M; Schaffalitzky de Muckadell OB; Lassen AT; Hansen JM; Hallas J
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1314-21. PubMed ID: 19716436
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.
Vidal X; Ibáñez L; Vendrell L; Conforti A; Laporte JR;
Drug Saf; 2008; 31(2):159-68. PubMed ID: 18217791
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.
Bell JS; Taipale HT; Soini H; Pitkälä KH
Clin Drug Investig; 2011; 31(5):337-44. PubMed ID: 21366362
[TBL] [Abstract][Full Text] [Related]
15. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population.
Helin-Salmivaara A; Huttunen T; Grönroos JM; Klaukka T; Huupponen R
Eur J Clin Pharmacol; 2007 Apr; 63(4):403-8. PubMed ID: 17347805
[TBL] [Abstract][Full Text] [Related]
16. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?
Dalton SO; Sørensen HT; Johansen C
CNS Drugs; 2006; 20(2):143-51. PubMed ID: 16478289
[TBL] [Abstract][Full Text] [Related]
17. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Tata LJ; Fortun PJ; Hubbard RB; Smeeth L; Hawkey CJ; Smith CJ; Whitaker HJ; Farrington CP; Card TR; West J
Aliment Pharmacol Ther; 2005 Aug; 22(3):175-81. PubMed ID: 16091054
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin re-uptake inhibitors and the risk of bleeding.
Weinrieb RM; Auriacombe M; Lynch KG; Lewis JD
Expert Opin Drug Saf; 2005 Mar; 4(2):337-44. PubMed ID: 15794724
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
Targownik LE; Bolton JM; Metge CJ; Leung S; Sareen J
Am J Gastroenterol; 2009 Jun; 104(6):1475-82. PubMed ID: 19491861
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding.
Lee MT; Park KY; Kim MS; You SH; Kang YJ; Jung SY
Yonsei Med J; 2020 Sep; 61(9):741-749. PubMed ID: 32882758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]